Tailoring traditional Chinese medicine in cancer therapy

中医药 癌症 癌症治疗 癌症治疗 癌症免疫疗法 精密医学 医学 免疫疗法 替代医学 内科学 病理
作者
Shuiquan Li,Xi Chen,Hui Shi,Ming Yi,Bing Xiong,Tianye Li
出处
期刊:Molecular Cancer [BioMed Central]
卷期号:24 (1): 27-27 被引量:114
标识
DOI:10.1186/s12943-024-02213-6
摘要

Cancer remains a formidable global health challenge, necessitating innovative therapeutic approaches to enhance treatment efficacy and reduce adverse effects. The traditional Chinese medicine (TCM), as an embodiment of ancient wisdom, has been validated to regulate the holistic human capacity against both internal and external "evils" in accordance with TCM principles. Therefore, it stands to reason to integrate TCM into current cancer therapy paradigms, such as chemotherapy, immunotherapy, and targeted therapy. This strategy conceptually intends to circumvent the inevitable side effects derived from present treatment, alleviate the discomfort, mollify the detrimental mood and synergize tumoricidal effects of distinct approaches. However, it is still vague whether TCM exert favorable function in cancer treatment. Therefore, it is imperative to retrieve and compile the existing literature on TCM in the realm of cancer, followed by a comprehensive recapitulation and synthesis of its core findings. Recently, with the advancement of contemporary biologic and medical theory and technology, it has become both feasible and imperative to elucidate the molecular signaling mechanisms and cellular biology underlying TCM. Specifically, leveraging TCM pharmaceutic components can not only directly impact tumor biology at the molecular level, but regulate the tumor immune environment through distinct pathways. Additionally, the administration of external TCM treatments such as acupuncture and moxibustion also demonstrates beneficial effects in cancer patients. Through comprehensive analysis, we demonstrated that TCM not only potentially increases the efficacy of conventional cancer treatments, but also significantly mitigates their toxic side effects, thereby prolonging patients' prognosis and improving their living quality. Furthermore, we have underscored the challenges and prospects associated with the integration of TCM into contemporary oncological practices, placing particular emphasis on the imperative for rigorous clinical trials and molecular investigations to substantiate the efficacy and safety of these combined therapeutic approaches. This synthesis aims to pave the way for a more integrated approach to cancer treatment rooted in both traditional wisdom and cutting-edge science.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
下雨打雷发布了新的文献求助10
2秒前
2秒前
2秒前
4秒前
4秒前
5秒前
5秒前
谷之森完成签到,获得积分10
5秒前
流行强度完成签到,获得积分10
5秒前
molihuakai应助Zxfff采纳,获得10
5秒前
科研通AI6.3应助111采纳,获得10
6秒前
小富发布了新的文献求助20
6秒前
7秒前
粒子一号完成签到,获得积分10
7秒前
可爱的函函应助甜橙汁采纳,获得10
8秒前
xie发布了新的文献求助10
8秒前
吴欣荃发布了新的文献求助10
9秒前
大模型应助单薄的南蕾采纳,获得10
10秒前
烟花应助活力的秋莲采纳,获得10
10秒前
乐乐应助Sea_U采纳,获得10
11秒前
科研通AI6.2应助ma采纳,获得10
12秒前
HWY完成签到,获得积分10
13秒前
sxmt123456789发布了新的文献求助10
14秒前
夏天发布了新的文献求助20
14秒前
绵马紫萁完成签到,获得积分10
15秒前
等待冰露完成签到 ,获得积分10
15秒前
壮观人达发布了新的文献求助10
16秒前
珹钰钰完成签到 ,获得积分10
18秒前
酷波er应助Howard采纳,获得10
18秒前
18秒前
青松完成签到,获得积分10
21秒前
sxmt123456789完成签到,获得积分10
21秒前
老小孩完成签到 ,获得积分10
21秒前
biubiubiu完成签到,获得积分10
22秒前
22秒前
徐院长发布了新的文献求助10
22秒前
小洲冲冲冲完成签到,获得积分10
22秒前
molihuakai应助不安傲松采纳,获得10
24秒前
小油菜完成签到,获得积分10
24秒前
高分求助中
Malcolm Fraser : a biography 700
Signals, Systems, and Signal Processing 610
天津市智库成果选编 600
Climate change and sports: Statistics report on climate change and sports 500
Forced degradation and stability indicating LC method for Letrozole: A stress testing guide 500
Organic Reactions Volume 118 400
A Foreign Missionary on the Long March: The Unpublished Memoirs of Arnolis Hayman of the China Inland Mission 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6461734
求助须知:如何正确求助?哪些是违规求助? 8270041
关于积分的说明 17629685
捐赠科研通 5532671
什么是DOI,文献DOI怎么找? 2906613
邀请新用户注册赠送积分活动 1883391
关于科研通互助平台的介绍 1729486